$1.71
-0.11-6.04%
Last update: Nov 5, 4:00 PM
TherapeuticsMD Inc
TXMDNASDAQ
TherapeuticsMD (TXMD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | — | — | — |
| Actual | $0.01 | $0.01 | $-0.06 | $0.00 |
| Surprise | — | — | — | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $869000 | $724000 | $893000 | $784000 |
| Surprise | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 14, 2023 | $-0.13 | $-0.05 | -160.0 % |
| Q2 | Aug 14, 2023 | $-0.24 | $-0.07 | -242.9 % |
| Q1 | May 15, 2023 | $-0.24 | $0.06 | -500.0 % |
| Q4 | Apr 7, 2023 | $-3.62 | $-1.11 | -226.1 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 14, 2023 | $-53.00K | $500.00K | -110.6 % |
| Q2 | Aug 14, 2023 | $437.00K | $500.00K | -12.6 % |
| Q1 | May 15, 2023 | $416.00K | $1.70M | -75.5 % |
| Q4 | Apr 7, 2023 | $1.15M | $23.80M | -95.2 % |
